Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushenpingchuan is a traditional Chinese medicine (TCM) formulation, most commonly encountered as "Bushenpingchuan granules." It is used in the context of TCM for the treatment of asthma, particularly in patients diagnosed with "kidney deficiency" syndrome according to TCM theory. The mechanism of action is not defined by modern pharmacology but is based on TCM principles aiming to "tonify the kidney" and support respiratory function. Clinical trials have evaluated its effect on inflammatory markers such as IL-6, TGF-beta, and IL-17 in asthma patients[1]. The product appears to be developed and studied primarily within China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushenpingchuan.